Applied dna awarded extension of health services contract with the city university of new york

Stony brook, n.y.--(business wire)---- $apdn #covid19--applied dna sciences, inc. (nasdaq: apdn) (the “company”), a leader in polymerase chain reaction (“pcr”)-based technologies, today announced that the city university of new york (cuny), the largest urban university in the united states, has extended its health services contract for covid-19 testing and vaccine policy management with the company's wholly-owned clinical laboratory subsidiary, applied dna clinical labs, llc (adcl), for 12 months through july 202
APDN Ratings Summary
APDN Quant Ranking